Laura A. Williams

Insider Reports History

Identity
Location
Boston, MA
SEC record
Reporting signature
/s/ Michael Raab, Attorney-in-Fact for Laura A. Williams
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Laura A. Williams:

Form 4 holding Chief Patient Officer

ARDELYX, INC.

Security class
Common Stock
Shares / value
429,093
Estimated value
$2,689,340
Report date
21 May 2026
Price
$6.27
Ownership
Direct
Form 4 holding Chief Patient Officer

ARDELYX, INC.

Security class
Stock Option (Right to Buy)
Shares / value
124,040
Estimated value
$365,864
Report date
23 Jan 2026
Price
$2.32
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

IMARA Inc.

Security class
Stock Option (right to buy)
Shares / value
8,500
Estimated value
Report date
02 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Laura A. Williams

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .